oncolex logo
Utskriftsdato 5.7.2020

References on intracranial tumors

  1. Helseth E et al. Intrakraniale svulster (517-538). Gjerstad L, Helseth E, Rootwelt T (Eds). Nevrologi og nevrokirurgi fra barn til voksen (5. utgave). Vett & Viten AS, Nesbru 2010.
  2. Cancer Registry of Norway. www.kreftregisteret.no
  3. Johannesen TB, Angell- Andersen E, Tretli S, Langmark F, Lote K. Trends in incidence of brain and central nervous system tumors in Norway 1970-1999. Neuroepidemiol 2004;23:101-109.
  4. Bhangoo ss et al. Evidence-Based Guidelines for the Management of Brain Metastases 2011
  5. Woodward ER, Wall K, Forsyth J, Macdonald F, Eamonn R. Maher ER. VHL mutation analysis in patients with isolated central nervous system heamangioblastoma. Brain 2007;130 (3):836-42.
  6. Louis DN et al. WHO classification of Tumoursof the Central Nervous System IARC Press Lyon 2007
  7. Hegi ME, DIserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M et al. MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma. N Engl J Med 2005;352:997-1003.
  8. Giannini C, Burger PC, Berkey BA, Cairncross JG, Jenkins RB, Mehta M et al. Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol. 2008:18 (3):360-369.
  9. Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 2005;103:1227-33.
  10. Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas. Cancer 2006;106:1358-63.
  11. Stupp R, Mason W, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. NEJM 2005:352:987-96.
  12. Helseth R et al. Overall survival, prognostic factores, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme Acta Neurol Scand: 2010: 159-167
  13. Rogne S et al. Intracranial tumor surgery in patients > 70 years of age: is clinical practice worthwhile or futile? Actal Neurol Scand 2009: 120: 288-294
  14. Lassen B et al. Surgical Mortality at 30 Days and Complications Leading to Recraniotomy in 2630 Consecutive Craniotomies for Intracranial Tumors Neurosurgery 68: 1259-1269, 2011
  15. Lancet oncol 2009; 10 (5): 459-
  16. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. Bethesda, MD